Jafron Biomedical Co.,Ltd. (300529.SZ) SHZ
18.13
-0.13(-0.71%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
18.13
-0.13(-0.71%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
2797
First IPO Date
August 02, 2016
| Name | Title | Pay | Year Born |
| Rui Wang | General Manager | 0 | 1962 |
| Cong Huang | Board Secretary | 0 | 1992 |
| Xueyun Liao | Director & Financial Director | 0 | 1977 |
| Fan Dong | Chairman of Board of Directors & GM | 0 | 1970 |
| Aijun Wu | Vice President | 0 | 1965 |
| De Zhi Li | Vice President | 0 | 1966 |
| Feng Li | VP & Non-Independent Director | 0 | 1970 |
| Xian Min Tang | VP & Director | 0 | 1970 |
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.